总的来说，这项研究，报道了对于伴有慢性肝病的HCC患者，肝切除术前行Y90治疗在增大FLR和抗肿瘤疗效方面均优于PVE。对于FLR不足的单侧HCC患者，肝切除术前的Y90治疗是一种较好的治疗策略，日后可进一步开展Y90作为比PVE更优效的替代疗法的研究。参考文献 [2]Hemming A W，Reed A I，Howard R J，et al. Pr...
[2] Hemming A W,Reed A I,Howard R J,et al. Preoperative portal vein embolization for extended hepatectomy [J]. Annals of surgery, 2003, 237(5): 686-691; discussion 691-683. [3] Liu H,Zhu S. Present status and future perspectives of preoperative portal vein embolization [J]. American...
Hepatocellular carcinoma (HCC) ranks among the most common cancers worldwide, representing the sixth most common one and the third cause of cancer-related death, and accounts for 7 % of all cancers [1]. HCC represents more than 90 % of primary liver canc
Complete portal vein thrombosis is, therefore, a contraindication to the use of TACE because this would lead to infarction and possible abscess of the treated area. The presence of a hepato-pulmonary shunt is also considered to be an absolute contraindication to the initiation or continuation of ...